HOME >> MEDICINE >> NEWS
Mount Sinai Researchers present findings on treatments for prostate and breast cancer

Researchers from the Department of Radiation Oncology and the Milton and Caroll Petrie Department of Urology at Mount Sinai School of Medicine are presenting findings from ten studies of prostate and breast cancer treatments at the 47th Annual Scientific Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO), October 16-20, 2005, in Denver, Colorado.

The research results being detailed:

  • A higher incidence of ATM gene variants in African American Women. (Lead author: G. Fan)
  • A significant percentage (at seven years minimum) of men with normal pre-treatment sexual function were able to experience a high rate of erectile function as quantified by the IIEF-5 and physician assigned a scoring system. (Lead author: J.A. Cesaretti)
  • Possession of a mutated ATM gene is associated with the development of grade 2 proctitis for patients treated with 125I brachytherapy. (Lead author: J.A. Cesaretti)
  • A specific genetic alteration is predictive for the development of late adverse radiotherapy responses among breast cancer patients treated with adjuvant radiation therapy. (Lead author: A.Y. Ho)
  • Prostate brachytherapy is generally well tolerated and appears to be safe in patients with a history of IBD. (Lead author: C.A. Peters)
  • If biologically effective doses can be achieved, excellent long-term biochemical and local control rates can be realized. (Lead author: R.G. Stock)
  • Overall long term morbidity associated with brachytherapy with or without HT and EBRT is low. (Lead author: N.N. Stone)
  • Insight into patient's erectile function post-brachytherapy can b well-assessed using the Mount Sinai Erectile Function Scale, along with, the International Index of Erectile Function-15. (Lead author: T.M. Zagar)
  • Ultrasound-guided brachytherapy is a reasonable salvage option for patients with biopsy proven biochemical recurrence following definitive external beam radiation therapy. (Lead author:
    '"/>


Contact: Mount Sinai Press Office
newsmedia@mssm.org
212-241-9200
The Mount Sinai Hospital / Mount Sinai School of Medicine
18-Oct-2005


Page: 1 2

Related medicine news :

1. New breakthrough treatment for spinal cancer patients at Mount Sinai
2. Mount Sinai and EXACT Sciences announce study results on study stool DNA testing for colon cancer
3. Wiley to assume publication of Mount Sinai Journal of Medicine
4. Mount Sinai researcher finds drinking water safe to drink
5. The Mount Sinai Medical Center recognized for excellence in bariatric surgery
6. Mount Sinai Global Health Center receives $1M grant
7. Mount Sinai School of Medicine receives prestigious AAMC Grant for Chronic Illness Care education
8. Mount Sinai and YAI/NIPD Network join forces to further quality of care for people with autism
9. Mount Sinai launches combination therapy trial to treat Relapsing-Remitting Multiple Sclerosis
10. CNIC commits 5 million Euros to the Mount Sinai School of Medicine
11. Mount Sinai expands cutting-edge molecular testing

Post Your Comments:
(Date:7/30/2015)... Marathon, FL (PRWEB) , ... July 30, 2015 ... ... streaming software, TikiLIVE, has worked to protect victims in San Diego, California’s Gaslamp ... cameras used by Gaslamp Quarter Plaza actively monitor the area for any ...
(Date:7/30/2015)... , ... July 30, 2015 , ... ... growing into one of the largest, family-owned low cost service and repair companies. ... commercial applications, as well as growing their company to meet the demands of ...
(Date:7/30/2015)... CA (PRWEB) , ... July ... ... recently released a video, “Beachside Nursing Center,” to announce its position as ... five-star ratings. Beachside's administrator and staff members support the CMS rating system, ...
(Date:7/30/2015)... , ... July 30, 2015 , ... Ross A. ... College of Medicine as Assistant Professor of Plastic Surgery. This is Dr. Clevens’ ... has worked closely with the university, developing a strong presence and a valuable mentoring ...
(Date:7/30/2015)... , ... July 30, 2015 , ... Using the latest ... and teach people more effective ways to prevent and manage major depression. , “Suicide ... fast enough, so people fall through the cracks and die needlessly everyday,” says Walker. ...
Breaking Medicine News(10 mins):Health News:Eyepartner Software Helps Victims in Gaslamp Quarter Plaza 2Health News:Eyepartner Software Helps Victims in Gaslamp Quarter Plaza 3Health News:Bill Howe Plumbing, Heating & Air Launches Online Application to Prospective Employees 2Health News:Bill Howe Plumbing, Heating & Air Launches Online Application to Prospective Employees 3Health News:Beachside Nursing Center Releases New Video 2Health News:Leading Melbourne Facial Plastic Surgeon Reappointed by UCF 2Health News:Leading Melbourne Facial Plastic Surgeon Reappointed by UCF 3Health News:Happiness Expert Develops Pioneering Online Tools for Sufferers of Major Depression, and Who may be Suicidal 2Health News:Happiness Expert Develops Pioneering Online Tools for Sufferers of Major Depression, and Who may be Suicidal 3
(Date:7/30/2015)... , July 30, 2015 Tianyin Pharmaceutical ... pharmaceutical company that specializes in the patented biopharmaceutical, modernized ... ingredients (API), provided updates regarding the notice it received ... (the "Exchange") indicating that the Company was below certain ... in Sections 134 and 1101 of the NYSE MKT ...
(Date:7/30/2015)... , July 30, 2015  Growth of the ... as they bring former prescription users to the OTC ... Kline forecasts robust Rx-to-OTC switch activity over the ... emerging along with many new brands entering the market ... over the next five years (even those with low ...
(Date:7/30/2015)... FAIRFIELD, N.J. , July 30, 2015 /PRNewswire/ ... Ferrer, completed the second Phase III clinical study ... development for impetigo.  Medimetriks owns the exclusive U.S. ... The global trial, conducted at 44 centers with ... and pediatric patients aged 2 months and older ...
Breaking Medicine Technology:TPI Provides Update Regarding Non-Compliance with NYSE MKT Continued Listing Requirements 2Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 2Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 3Medimetriks Pharmaceuticals, Inc. Announces Completion of the Second Successful Pivotal Phase III Study for Ozenoxacin 2Medimetriks Pharmaceuticals, Inc. Announces Completion of the Second Successful Pivotal Phase III Study for Ozenoxacin 3
Cached News: